Titan Medical Announces Availability of Materials for the 2022 Annual and Special Meeting of Shareholders
May 06 2022 - 1:23PM
Business Wire
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device
company focused on the development and commercialization of
innovative surgical technologies for single access robotic-assisted
surgery (RAS), today announced that its 2022 Annual and Special
Meeting (“the Meeting”) is scheduled for Wednesday, June 8, 2022 at
4:00 p.m. ET to be held virtually at
https://web.lumiagm.com/432237190.
As described in the distributed proxy materials, shareholders
are entitled to notice of, and to vote at, the Meeting and at any
adjournment or postponement thereof if they were a shareholder of
record as of the close of business on May 26, 2022. The directors
have fixed 4:00 p.m. ET on June 6, 2022, or at least 48 hours,
excluding Saturdays and holidays, before any adjournment of the
meeting, as the time before which proxies to be used at the Meeting
(or any adjournment thereof) must be deposited with the company or
with Computershare Trust Company of Canada.
Items to be presented and voted on at the Meeting include the
following:
- Presentation of the audited financial statements of the
Corporation for the fiscal year ended December 31, 2021.
- Election of directors of the company for the ensuing year.
- Appointment as auditors of BDO Canada LLP, the incumbent
auditors of the company, and authorize directors to fix the
remuneration of the auditors.
- Approve the renewal and amendment the company’s share unit
plan.
- Approve the renewal and amendment of the company’s deferred
share unit plan.
- Approve the adoption of an employee share purchase plan.
- Transact such other business as may properly come before the
meeting or any adjournments thereof.
Further information regarding the matters to be acted upon at
the Annual Meeting is set forth in the proxy statement and other
proxy materials for the Annual Meeting, which are available at
https://ir.titanmedicalinc.com/news-events/annual-shareholder-meeting-2022.
If you have any questions or require more information with
regard to the procedures for voting, please contact Shorecrest
Group, by (i) telephone at 1-888-637-5789 (North American
Toll-Free) or 1-647-931-7454 (Collect Calls Outside North America),
or (ii) email at contact@shorecrestgroup.com.
About Titan Medical
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device
company headquartered in Toronto, Ontario, with operations in
Chapel Hill, North Carolina, is focused on enhancing
robotic-assisted surgery (RAS) using innovative technology through
a single access point. The Enos™ robotic single access surgical
system is being developed with an ergonomic focus to provide a
surgical experience that imitates real-life movements that surgeons
demand. The Enos system includes multi-articulating instruments
designed to allow surgeons an increased range of motion in a
confined space, with dexterity and the ability to exert the forces
necessary to complete common surgical tasks. Titan intends to
initially pursue gynecologic surgical indications with the Enos
system.
Enos™ is a trademark of Titan Medical Inc.
For more information, visit www.titanmedicalinc.com and follow
@TitanMedical on Twitter and LinkedIn.
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of applicable Canadian and U.S. securities laws, which
reflect the current expectations of management of the company’s
future growth, results of operations, performance and business
prospects and opportunities. Forward-looking statements are
frequently, but not always, identified by words such as “may”,
“would”, “could”, “will”, “anticipate”, “believe”, “plan”,
“expect”, “intend”, “estimate”, “potential for” and similar
expressions, although these words may not be present in all
forward-looking statements. Forward-looking statements that appear
in this release may include, without limitation, references to:
These statements reflect management’s current beliefs with respect
to future events and are based on information currently available
to management. Forward-looking statements involve significant
risks, uncertainties and assumptions. Many factors could cause the
company’s actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such
forward-looking statements, including, without limitation, those
listed in the “Risk Factors” section of the company’s Annual Report
for the fiscal year ended December 31, 2021 which may be viewed at
www.sedar.com and at www.sec.gov. Should one or more of these risks
or uncertainties materialize, or should assumptions underlying the
forward-looking statements prove incorrect, actual results,
performance, or achievements may vary materially from those
expressed or implied by the forward-looking statements contained in
this news release. These factors should be considered carefully,
and prospective investors should not place undue reliance on the
forward-looking statements. Although the forward-looking statements
contained in the news release are based upon what management
currently believes to be reasonable assumptions, the company cannot
assure prospective investors that actual results, performance or
achievements will be consistent with these forward-looking
statements. Except as required by law, the company expressly
disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220506005469/en/
Kristen Galfetti Vice President, Investor Relations &
Corporate Communications +1-781-869-2553
investors@titanmedicalinc.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2023 to Apr 2024